Claudia G.
- Country
- Germany
- Department
- Klinik und Poliklinik für Dermatologie
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adults with Bullous Pemphigoid: An Open-label Extension Study
- Efficacy and Safety Evaluation of Fipaxalparant in Diffuse Cutaneous Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
- Efficacy and Safety of Daxdilimab in Adults with Moderate-to-Severe Primary Discoid Lupus Erythematosus: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 67 of 138 partner sites.
Specializations
Lupus Research Focus
This investigator specializes in various forms of lupus erythematosus, particularly focusing on cutaneous manifestations. Their research encompasses subacute cutaneous lupus, chronic cutaneous lupus, and discoid lupus erythematosus.
- Cutaneous Lupus Management
- Systemic Lupus Complications
- Novel Therapeutic Approaches
Autoimmune Skin Conditions
The investigator conducts research in severe autoimmune skin disorders, with particular emphasis on bullous pemphigoid and dermatomyositis. Their work includes evaluation of innovative therapeutic agents for these challenging conditions.
- Autoimmune Blistering Diseases
- Inflammatory Muscle Disorders
- Immunological Treatments
Systemic Sclerosis Studies
A significant focus of research is on diffuse cutaneous systemic sclerosis. The investigator studies disease progression and therapeutic interventions for this complex autoimmune condition.
- Skin Fibrosis Management
- Pulmonary Complications
- Long-term Disease Outcomes
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.